S426-0152 Screening compound: N~1~-(3,5-dimethylphenyl)-3-[5-(methoxymethyl)-1,2,4-oxadiazol-3-yl]tetrahydro-1(2H)-pyridinecarboxamide

S426-0152 Screening compound: N~1~-(3,5-dimethylphenyl)-3-[5-(methoxymethyl)-1,2,4-oxadiazol-3-yl]tetrahydro-1(2H)-pyridinecarboxamide
S426-0152 Screening compound: N~1~-(3,5-dimethylphenyl)-3-[5-(methoxymethyl)-1,2,4-oxadiazol-3-yl]tetrahydro-1(2H)-pyridinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S426-0152
N~1~-(3,5-dimethylphenyl)-3-[5-(methoxymethyl)-1,2,4-oxadiazol-3-yl]tetrahydro-1(2H)-pyridinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S426-0152

Molecular Formula

C18H24N4O3 (C18 H24 N4 O3)

Compound Name

N~1~-(3,5-dimethylphenyl)-3-[5-(methoxymethyl)-1,2,4-oxadiazol-3-yl]tetrahydro-1(2H)-pyridinecarboxamide

IUPAC name

N-(35-dimethylphenyl)-3-[5-(methoxymethyl)-124-oxadiazol-3-yl]piperidine-1-carboxamide

SMILES

Cc1cc(NC(N(CCC2)CC2c2noc(COC)n2)=O)cc(C)c1

InChI

InChI=1S/C18H24N4O3/c1-12-7-13(2)9-15(8-12)19-18(23)22-6-4-5-14(10-22)17-20-16(11-24-3)25-21-17/h7-9,14H,4-6,10-11H2,1-3H3,(H,19,23)/t14-/m0/s1

InChI Key

IQTMFBAAEQVPBP-AWEZNQCLSA-N

MDL Number (MFCD)

MFCD28994495

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

344.41

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.883

Distribution Coefficient, logD

2.883

Water Solubility, LogSw

-3.03

Polar Surface Area

65.408

Acid Dissociation Constant (pKa)

14.29

Base Dissociation Constant (pKb)

1.16

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

S426-0152 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Eye
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Targets:
  • Ion Channels
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S426-0152 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S426-0152?
Check Price and Availability of S426-0152, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S426-0152 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S426-0152
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S426-0152
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S426-0152 available by request